Reduced-intensity, risk factor–stratified immunosuppression for acquired hemophilia A: single-center observational study

Immunosuppressive therapy (IST) is administered to patients with acquired hemophilia A (AHA) to eradicate autoantibodies against coagulation factor VIII (FVIII). Data from registries previously demonstrated that IST is often complicated by adverse events, in particular infections. This pilot study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobbelstein, Christiane, Moschovakis, Georgios Leandros, Tiede, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419459/
https://www.ncbi.nlm.nih.gov/pubmed/32621181
http://dx.doi.org/10.1007/s00277-020-04150-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419459/
https://www.ncbi.nlm.nih.gov/pubmed/32621181
http://dx.doi.org/10.1007/s00277-020-04150-y

Ejemplares similares